摘要:
The invention concerns the treatment of orthomyxovirus infections with inhibitors of the ubiquitin protease system, in particular proteasome inhibitors.
摘要:
A metal rod-shaped element for a liquid detecting device is essentially cylindrical and has first and second ends. In at least one length, starting from the second end, the element has an isolating coating and an electrode strip is provided which extends along a longitudinal axis of the element. The electrode strip is not electrically connected to the element and the strip comprises a high impedance material. Two flattened sections are provided where the metal of the element lies openly. In a cross sectional view the electrode strip is situated between the two flattened sections. A first contact mechanism is provided in order to establish, in the range of the first end, an electrical contact to the rod-shaped element, and a second contact mechanism is provided in order to establish, within the range of the first end, an electrical contact to the electrode strip.
摘要:
The invention relates to agents for the treatment, therapy and inhibition of Flaviviridae virus infections, which agents comprise proteasome inhibitors as the active component. The agents which are used for inhibiting the release, maturation and replication of Flaviviridae comprise, as the active component in pharmaceutical preparations, substance classes which share the common property of inhibiting the 26S proteasome in cells. These substance classes include, in particular, proteasome inhibitors which affect the activities of the ubiquitin/proteasome pathway, in particular the enzymic activities of the 26S and the 20S proteasome complex. The application of the invention lies in the antiviral therapy of Flaviviridae infections, especially in preventing the establishment and maintenance of a chronic hepatitis C virus infection and a hepatopathogenesis which is associated therewith.
摘要:
A procedure for the release and isolation of nucleic acids from biological compartments of a sample always uses an instrument that can hold one or more sample processsing vessels, maintain the sample processing vessels at a constant temperature, shake the sample processing vessels and separate magnetic particles by means of magnetic force. This system greatly simplifies the isolation of nucleic acids.
摘要:
The invention relates to aerogels containing functional residues of the formula (I)--Y--Z, wherein Y is a straight-chained or branched alkylene group with 1 to 22 carbon atoms; Z is halogen, pseudohalogen, SR.sup.1, PR.sup.2 R.sup.3, colorant residue or metal complex residue; R.sup.1 is H, a straight-chained or branched alkyl group with 1 to 22 carbon atoms or an aryl group with 4 to 10 carbon atoms; and R.sup.2 and R.sup.3 are identical or different, a straight-chained or branched alkyl group with 1 to 22 carbon atoms, or an aryl group with 4 to 10 carbon atoms. The aerogels are suitable, for example, as catalyst stayes and/or sensors. They can be obtained by metal alcoholates and metal alcoholates in which at least one alcoholate residue is replaced by the --Y--Z group being converted into a lyogel by hydrolysis and condensation, and subsequently being dried.
摘要:
The problem addressed was that of providing novel polymers which are preparable with a low level of complexity, with the possibility of controlled influence on the physicochemical properties thereof within wide limits in the course of synthesis, and which are usable as active media in electrical charge storage elements for high storage capacity, long lifetime and stable charging/discharging plateaus.9,10-Bis(1,3-dithiol-2-ylidene)-9,10-dihydroanthracene polymers consisting of an oligomeric or polymeric compound of the general formula I have been found.
摘要:
The invention relates to a composition for the corrosion protection of metal substrates and to the production thereof, and to a method for producing corrosion-resistant coatings.
摘要:
The invention relates to agents for the treatment, therapy and inhibition of Flaviviridae virus infections, which agents comprise proteasome inhibitors as the active component. The agents which are used for inhibiting the release, maturation and replication of Flaviviridae comprise, as the active component in pharmaceutical preparations, substance classes which share the common property of inhibiting the 26S proteasome in cells. These substance classes include, in particular, proteasome inhibitors which affect the activities of the ubiquitin/proteasome pathway, in particular the enzymic activities of the 26S and the 20S proteasome complex. The application of the invention lies in the antiviral therapy of Flaviviridae infections, especially in preventing the establishment and maintenance of a chronic hepatitis C virus infection and a hepatopathogenesis which is associated therewith.
摘要:
The present invention provides screening methods for identifying a compound that induces loss of the lentiviral protein Vpr; screening methods for identifying compounds that inhibit the peptidyl-prolyl cis/trans isomerase (PPIase) activity of a protein that catalyzes cis-trans isomerization of cis-peptidylprolyl bonds in Vpr; and compounds identified by the screening methods. The compounds are useful for treating a lentiviral infection. The present invention further provides methods of inducing loss of the lentiviral protein Vpr; methods of inhibiting lentivirus viral replication; and methods of treating a lentivirus infection in an individual. The methods generally involve administering to an individual infected with the lentivirus an effective amount of a compound that induces Vpr loss and/or that inhibits PPIase activity of a protein that catalyzes cis-trans isomerization of cis-peptidylprolyl bonds in Vpr.